Skip to main content

Peer Review reports

From: The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data

Original Submission
16 Feb 2024 Submitted Original manuscript
8 Mar 2024 Reviewed Reviewer Report
12 Mar 2024 Reviewed Reviewer Report
10 Apr 2024 Author responded Author comments - Ni Yuan
Resubmission - Version 2
10 Apr 2024 Submitted Manuscript version 2
12 Apr 2024 Author responded Author comments - Ni Yuan
Resubmission - Version 3
12 Apr 2024 Submitted Manuscript version 3
16 Apr 2024 Author responded Author comments - Ni Yuan
Resubmission - Version 4
16 Apr 2024 Submitted Manuscript version 4
19 Apr 2024 Reviewed Reviewer Report
27 Apr 2024 Reviewed Reviewer Report
3 May 2024 Author responded Author comments - Ni Yuan
Resubmission - Version 5
3 May 2024 Submitted Manuscript version 5
6 May 2024 Reviewed Reviewer Report
9 May 2024 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
9 May 2024 Editorially accepted
14 May 2024 Article published 10.1186/s12889-024-18820-3

You can find further information about peer review here.

Back to article page